Nvidia Q1 Preview: Jensen Will Bring Home A Win

Nvidia is viewed as a long-term buy ahead of its May 20 earnings, despite recent underperformance versus the semiconductor sector. Q1 guidance assumes zero China data center revenue, so any improvement in China could be a meaningful upside catalyst. GPU demand remains exceptionally strong globally, with Blackwell B200 availability at 0% and rental rates still elevated.

Analysis

The setup is still favorable, but the market is underestimating how asymmetric the next two quarters could be for the AI supply chain. If NVDA can re-open even a modest China data-center stream, the incremental revenue would mostly fall through to gross profit because the fixed-cost base is already leveraged to full utilization; that means upside from policy relief can hit earnings much harder than a simple revenue bridge implies. The second-order winner is not just NVDA — it is also the advanced packaging, HBM, and foundry ecosystem, where tightness can persist even if end-demand wobbles because allocation discipline keeps pricing firm.

The bigger risk is not demand decay but expectation saturation. When availability is effectively zero and rental economics remain elevated, the market starts to treat scarcity as permanent, which is dangerous if management gives any hint that lead times are normalizing or that customer mix is shifting toward lower-margin configurations. In that case, the stock can de-rate even with robust absolute demand, because the multiple has been built on an assumption of relentless upward revisions rather than just strong results.

Over the next 1-4 weeks, the key catalyst is guidance language on China and Blackwell ramp cadence; over the next 3-6 months, the swing factor is whether hyperscalers and sovereign buyers broaden capex enough to absorb supply without pricing pressure. The contrarian view is that the recent underperformance may be a buying opportunity not because NVDA is cheap, but because positioning likely got lighter into earnings while the fundamental inflection could arrive before consensus has time to re-rate the supply chain. The risk/reward still skews positive, but only if one avoids paying up for upside that is already embedded in the broad AI basket.

Key Decisions for Investors

• Initiate/keep a tactical long NVDA into earnings with a defined risk: use a 2-4 week call spread rather than outright stock to capture a China-guidance upside surprise while limiting pre-print premium decay.
• Pair long NVDA vs short a semis basket with less direct AI leverage (e.g., NVDA / SOXX equal-dollar hedge) for 1-2 months; thesis is that NVDA-specific supply scarcity and China optionality should outperform the broader sector if guidance is constructive.
• Buy weakness in the AI supply chain on any post-earnings knee-jerk selloff: prioritize names exposed to HBM/advanced packaging/foundry bottlenecks for a 3-6 month horizon, as those bottlenecks can keep pricing power intact even if NVDA volatility spikes.
• Use downside protection if holding spot NVDA: finance a long position by selling an OTM call into the event, or hedge with short-dated puts if management commentary signals Blackwell availability improvement faster than expected.
• Set a catalyst trigger to add aggressively only if management signals any China reopening or export-control easing; that scenario is a high-beta earnings revision catalyst and likely more powerful than the headline print itself.